Alterations in the cell cycle and in the protein level of cyclin D1, p21CIP1, and p16INK4a after exposure to 50 Hz MF in human cells

Radiation and Environmental Biophysics

Volumn 41, Issue 2, 2002, Pages 131-137

  Lange, Sandra ^a   Richard, Doreen ^a   Viergutz, Torsten ^b   Kriehuber, Ralf ^a   Weiss, Dieter G ^a   Simkó, Myrtill ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b LEIBNIZ INSTITUTE FOR FARM ANIMAL BIOLOGY FBN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P16; PROTEIN P21; CDK4 PROTEIN, HUMAN; CDKN1A PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; ONCOPROTEIN; PROTEIN P16INK4A;

ARTICLE; CALCIUM CELL LEVEL; CARCINOGENESIS; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; DNA REPAIR; ELECTROMAGNETIC FIELD; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MAGNETIC FIELD; MITOSIS RATE; OSCILLATION; RADIATION EXPOSURE; AMNION FLUID; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DIPLOIDY; METABOLISM; RADIATION RESPONSE; REFERENCE VALUE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STEM CELL;

HELIOTHIS ZEA VIRUS 1;

AMNIOTIC FLUID; CELL CYCLE; CELL CYCLE PROTEINS; CELLS, CULTURED; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; DIPLOIDY; DOSE-RESPONSE RELATIONSHIP, RADIATION; ELECTROMAGNETIC FIELDS; G1 PHASE; HUMANS; PROTO-ONCOGENE PROTEINS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; S PHASE; SENSITIVITY AND SPECIFICITY; STEM CELLS;

EID: 0036618220     PISSN: 0301634X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00411-002-0145-8     Document Type: Article

References (42)

1. Portier CJ, Wolfe MS (eds) (1998) Assessment of health effects from exposure to power-line frequency electric and magnetic fields. National Institute of Environmental Health Sciences Working Group Report. NIH Publication No. 98-3981. U.S.National Institutes of Health, Bethesda
2. Theriault G, Goldberg M, Miller AB, Armstrong B, Guenel P, Deadman J, Imbemon E, To T, Chevalier A, Cyr D (1994) Cancer risks associated with occupational exposure to magnetic fields among electric utility workers in Ontario and Quebec, Canada, and France: 1970-1989. Am J Epidemiol 139:1053
3. Guenel P, Nicolau J, Imbernon E, Chevalier A, Goldberg M (1996) Exposure to 50 Hz electric field and incidence of leukemia, brain tumors, and other cancers among French electric utility workers. Am J Epidemiol 144:1107-1121
4. Liburdy RP, Callahan DE, Harland J, Dunham E, Sloma TR, Yaswen P (1993) Experimental evidence for 60 Hz magnetic fields operating through the signal transduction cascade. Effects on calcium influx and c-MYC mRNA induction. FEBS Lett 334:301-308
5. Phillips JL, Haggren W, Thomas WJ, Ishida-Jones T, Adey WR (1992) Magnetic field-induced changes in specific gene transcription. Biochim Biophys Acta 1132:140-144
6. Mullins JM, Penafiel LM, Juutilainen J, Litovitz TA (1999) Dose-response of electromagnetic field-enhanced ornithine decarboxylase activity. Bioelectrochem Bioenerg 48:193-199
7. Lindström E, Lindström P, Berglund A, Mild KH, Lundgren E (1993) Intracellular calcium oscillations induced in a T-cell line by a weak 50 Hz magnetic field. J Cell Physiol 156:395-398
8. Miyakoshi J, Ohtsu S, Shibata T, Takebe H (1996) Exposure to magnetic field (5 mT at 60 Hz) does not affect cell growth and c-myc gene expression. J Radiat Res (Tokyo) 37:185-191
9. Linet MS, Hatch EE, Kleinerman RA, Robison LL, Kaune WT, Friedman DR, Severson RK, Haines CM, Hartsock CT, Niwa S, Wacholder S, Tarone RE (1997) Residential exposure to magnetic fields and acute lymphoblastic leukemia in children. N Engl J Med 337:1-7
10. Repacholi MH, Greenebaum B (1999) Interaction of static and extremely low frequency electric and magnetic fields with living systems: health effects and research needs. Bioelectromagnetics 20:133-160
11. Juutilainen J, Lang S, Rytomaa T (2000) Possible cocarcinogenic effects of ELF electromagnetic fields may require repeated long-term interaction with known carcinogenic factors. Bioelectromagnetics 21:122-128
12. Simkó M, Kriehuber R, Lange S (1998) Micronucleus formation in human amnion cells after exposure to 50 Hz MF applied horizontally and vertically. Mutat Res 418:101-111
13. Morgan DO (1995) Principles of CDK regulation. Nature 374:131-134
14. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato JY (1994) D-Type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 14:2066-2076
15. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, Arnold A (1991) A novel cyclin encoded by a bcl 1-linked candidate oncogene. Nature 350:512-515
16. Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512
17. Serrano M, Hannon GJ, Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704-707
18. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D (1993) p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704
19. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS 3rd, Johnson BE, Skolnick MH (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440
20. Vidal MJ, Loganzo F Jr, de-Oliveira AR, Hayward NK, Albino AP (1995) Mutations and defective expression of the WAF1 p21 tumour-suppressor gene in malignant melanomas. Melanoma Res 5:243-250
21. Eremenko T, Esposito C, Pasquarelli A, Pasquali E, Volpe P (1997) Cell cycle kinetics of friend erythroleukemia cells in a magnetically shielded room and in a low-frequency/low-intensity magnetic field. Bioelectromagnetics 18:58-66
22. Nindl G, Swez JA, Miller JM, Balcavage WX (1997) Growth stage dependent effects of electromagnetic fields on DNA synthesis of Jurkat cells. FEBS Lett 414:501-506
23. Coppock DL, Buffolino P, Kopman C, Nathanson L (1995) Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity. Exp Cell Res 221:92-102
24. Cridland NA, Haylock RG, Saunders RD (1999) 50 Hz Magnetic field exposure alters onset of S-phase in normal human fibroblasts. Bioelectromagnetics 20:446-452
25. Schimmelpfeng J, Dertinger H (1993) The action of 50 Hz magnetic and electric fields upon cell proliferation and cyclic AMP content of cultured mammalian cells. Bioelectrochem Bioenerg 30:143-150
26. Zhao YL, Johnson PG, Jahreis GP, Hui SW (1999) Increased DNA synthesis in INIT/10T1/2 cells after exposure to a 60 Hz magnetic field: a magnetic-field or a thermal effect? Radiat Res 151:201-208
27. Wei M, Guizzetti M, Yost M, Costa LG (2000) Exposure to 60 -Hz magnetic fields and proliferation of human astrocytoma cells in vitro. Toxicol Appl Pharmacol 162:166-176
28. Goodman R, Weisbrot D, Uluc A, Henderson A (1992) Transcription in Drosophila melanogaster salivary gland cells is altered following exposure to low-frequency electromagnetic fields: analysis of chromosome 3R. Bioelectromagnetics 13:111-118
29. Schimmelpfeng J, Dertinger H (1997) Action of a 50 Hz magnetic field on proliferation of cells in culture. Bioelectromagnetics 18:177-183
30. Brunborg G, Holme JA, Hongslo JK (1995) Inhibitory effects of paracetamol on DNA repair in mammalian cells. Mutat Res 342:157-170
31. Eremenko T, Tartaglini E, Volpe P (1995) Regulation of DNA repair and replication in proliferating FL cells. Phys Proc Acad Lincei 6:299-312
32. Imoto M, Doki Y, Jiang W, Han EK, Weinstein IB (1997) Effects of cyclin D1 overexpression on G1 progression-related events. Exp Cell Res 236:173-180
33. Reed MF, Liu VF, Ladha MH, Ando K, Griffin JD, Weaver DT, Ewen ME (1998) Enforced CDK4 expression in a hematopoietic cell line confers resistance to the G1 arrest induced by ionizing radiation. Oncogene 17:2961-2971
34. Dees C, Garrett S, Henley D, Travis C (1996) Effects of 60 Hz fields, estradiol and xenoestrogens on human breast cancer cells. Radiat Res 146:444-452
35. Xiong Y, Zhang H, Beach D (1992) D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71:505-514
36. Parry D, Bates S, Mann DJ, Peters G (1995) Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. EMBO J 14:503-511
37. Lukas J, Parry D, Aagaard L, Mann DJ, Bartkova J, Strauss M, Peters G, Bartek J (1995) Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375:503-506
38. Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L, Swindell E (1995) Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 6:387-400
39. Ball KL (1997) p21: Structure and functions associated with cyclin-CDK binding. Prog Cell Cycle Res 3:125-134
40. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E (1997) New functional activities for the p21 family of CDK inhibitors. Genes Dev 11:847-862
41. Matsushime H, Ewen ME, Strom DK, Kato JY, Hanks SK, Roussel MF, Sherr CJ (1992) Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell 71:323-334
42. Kip1 CDK "inhibitors" are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 18:1571-1583